(Q51691332)

9 April 2018

title

Progression in ALS is not linear but is curvilinear. (English)

1 reference

9 April 2018

amyotrophic lateral sclerosis

main subject

1 reference

1

1 reference

9 April 2018

Vincent Meininger

8

object named as

Vincent Meininger

1 reference

9 April 2018

6

Philippe Corcia

1 reference

9 April 2018

Pierre-François Pradat

4

object named as

Pierre-Francois Pradat

1 reference

9 April 2018

Bin Cheng

2

1 reference

9 April 2018

Francois Salachas

3

1 reference

9 April 2018

Gaelle Bruneteau

5

1 reference

9 April 2018

Lucette Lacomblez

7

1 reference

9 April 2018

publication date

8 June 2010

1 reference

9 April 2018

published in

Journal of Neurology

1 reference

9 April 2018

volume

257

1 reference

9 April 2018

issue

10

1 reference

9 April 2018

page(s)

1713-1717

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s00415-010-5609-1

exact match

0 references

cites work

The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-010-5609-1

The rate of decline in function in Alzheimer's disease and other dementias.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-010-5609-1

Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL.

21 January 2018

1 reference

12 December 2020

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

1 reference

12 December 2020

Natural history of amyotrophic lateral sclerosis. A discussion

1 reference

12 December 2020

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials

1 reference

12 December 2020

Defining survival as an outcome measure in amyotrophic lateral sclerosis.

1 reference

12 December 2020

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note

1 reference

12 December 2020

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

12 December 2020

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

1 reference

12 December 2020

Amyotrophic lateral sclerosis

1 reference

12 December 2020

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

1 reference

12 December 2020

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial

1 reference

12 December 2020

Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis.

1 reference

12 December 2020

Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months

1 reference

12 December 2020

ALS trial design: expectation and reality

1 reference

12 December 2020

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

1 reference

12 December 2020

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

1 reference

12 December 2020

Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

1 reference

12 December 2020

The association of CAG repeat length with clinical progression in Huntington disease

1 reference

12 December 2020

A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis

1 reference

12 December 2020

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

12 December 2020

Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.

1 reference

12 December 2020

Patterns of levodopa response in Parkinson's disease: a clinico-pathological study

1 reference

12 December 2020

Improving efficiency of ALS clinical trials using lead‐in designs

1 reference

12 December 2020

Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.

1 reference

12 December 2020

10.1007/S00415-010-5609-1

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018